What is the BCRX stock price prediction for next 2 weeks?

According to our price prediction algorithm,BioCryst Pharmaceuticals, Inc. (BCRX) price will be around $5.98 in the next 2 weeks. This means it will decrease by -10.27586206896551 from the last closing price. This prediction may vary from other time period filters for BCRX stock.

What can be the highest Possible price of BCRX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BCRX can achieve the highest price of $6.28 which is -5.879850722659543 lower than last closing price. This prediction may vary from other time period filters for BCRX stock.

What can be the lowest Possible price of BCRX stock in next 2 weeks?

As per the forecast and algorithmic analysis, BCRX stock price can be as low as $5.71 which is -14.441877383527657 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for BCRX stock.

Will BCRX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that BCRX stock will lose-10.27586206896551 in the next 2 weeks. This prediction may vary from other time period filters for BCRX stock.

What is BCRX stock last closing price?

Last closing price of BCRX stock was $6.67.

What is BCRX stock price prediction?

BCRX stock price prediction means predicting the future closing prices of BCRX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BCRX stock in a certain time period.

How we predict BCRX stock future prices?

If you are searching for BCRX stock forecast, analysis or price prediction, then you might be wondering what BioCryst Pharmaceuticals, Inc. (BCRX) will do in the future. Our BCRX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BCRX price prediction will likely answer most of your questions.

How frequent we update BCRX stock predictions?

We are updating the forecasts for the BCRX stock on daily basis.

Is using ML forecasting for BCRX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BCRX stock same for all the time periods?

No, the prediction for BCRX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

BioCryst Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$6.67-15.78%Since 2 Weeks

Predicted Price$5.98-10.28%For 2 Weeks

Upper Predicted Price$6.28-5.88%For 2 Weeks

Lower Predicted Price$5.71-14.44%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BCRX will decline by -10.28% over the next 2 Weeks and hit $5.98 by Tuesday, February 3, 2026. In that time frame, BCRX's share price is expected to range between $5.71 and $6.28.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 3, 2026	5.71	5.98	6.28
Feb 2, 2026	5.83	6.09	6.35
Jan 30, 2026	5.92	6.19	6.46
Jan 29, 2026	6.28	6.53	6.79
Jan 28, 2026	6.11	6.39	6.67
Jan 27, 2026	6.07	6.33	6.58
Jan 26, 2026	6.16	6.43	6.69
Jan 23, 2026	6.25	6.53	6.79
Jan 22, 2026	6.60	6.88	7.12
Jan 21, 2026	6.47	6.73	6.98

BCRX shares rose +0.82% in Wednesday, January 21, 2026's trading session, rising from a previous close of $6.67 to move at $6.73. The stock demonstrated notable intraday movement (see BCRX's key stats for a full breakdown), fluctuating between $6.60 and $6.74, a +2.12% trading range. While recent weeks have seen some volatility, BCRX has managed to secure a -11.28% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 5.41M shares changing hands, 1.31M fewer than the previous session. This amounted to $36.36M in total market activity.

Will BCRX Continue Its Downward Trend?

According to analyst ratings and projections for BCRX, BioCryst Pharmaceuticals, Inc. shares are anticipated to decrease by -7.12%, potentially reaching $6.28 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for BCRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the BCRX stock forecast, now is not the best time to buy BCRX stock because its current trading price is +12.37% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BCRX covering social and institutional perspectives.

BCRX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BCRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 35.31% to 40.93%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 44.58%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.58%, maintains a neutral outlook for the long term. Insights into BCRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

BioCryst Pharmaceuticals Short-Term Forecasts

BCRX Forecast For Next 5 Days

Our algorithm anticipates BioCryst Pharmaceuticals (BCRX) stock could hit $7.06 by Jan 28, 2026. This represents a +5.02% fall from today's price, following a -5.92% change over the past five days.

BCRX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for BioCryst Pharmaceuticals, Inc. (BCRX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $6.89, which would mean a +2.45% increase from the current price of $6.73. Projections for this period range from a high of $7.60 to a low of $6.18.

BCRX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for BioCryst Pharmaceuticals's price over the next three months point to a rise. BCRX stock is expected to peak at $17.45 on Feb 16, 2026 before potentially dipping to $12.73 on Apr 13, 2026. On average, BCRX is likely to trade around $15.51 in the coming 90 days.

BioCryst Pharmaceuticals Stock Forecast 2025

Based on our predictive models, BioCryst Pharmaceuticals (BCRX) is expected to trade between $7.55 and $19.30 throughout 2026. This would result in an average price of $14.49, potentially offering investors a +115.46% return from current levels.

BioCryst Pharmaceuticals, Inc. Monthly Forecast 2026–2027

January 2026

According to our latest forecast models, BioCryst Pharmaceuticals, Inc. (BCRX) is positioned to show a strong performance in January 2026. The price is predicted to move between $15.44 and $16.22, settling at an average of $15.84. This could translate to a +135.54% gain.

February 2026

Based on current market signals, BioCryst Pharmaceuticals, Inc. is projected to trend february 2026. We forecast a trading range from $15.51 to $17.45, with a likely average price of $16.76. Investors could expect a potential return of +149.22%.

March 2026

Our predictive algorithms indicate BioCryst Pharmaceuticals, Inc. stock may see a shift in March 2026. The expected range spans $14.71–$16.65, with an average target of $15.53. This represents a positive outlook and a possible gain of +130.93%.

April 2026

Analyzing established trends, BioCryst Pharmaceuticals, Inc. looks set to move in April 2026. Projections place the stock between $12.73 and $15.16, averaging around $13.78. This suggests a +104.91% gain from current levels.

May 2026

Market indicators suggest BioCryst Pharmaceuticals, Inc. could experience notable changes during May 2026. Prices could fluctuate within $14.29 to $19.05, with a midpoint forecast of $17.28. The stock might deliver a +156.95% gain.

June 2026

Forecasting for June 2026, models estimate that BioCryst Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $13.80 and $19.30, averaging $17.37. This signals a positive trajectory with potential returns around +158.29%.

July 2026

According to our latest forecast models, BioCryst Pharmaceuticals, Inc. (BCRX) is positioned to show a strong performance in July 2026. The price is predicted to move between $13.33 and $16.92, settling at an average of $15.11. This could translate to a +124.68% gain.

August 2026

Based on current market signals, BioCryst Pharmaceuticals, Inc. is projected to trend august 2026. We forecast a trading range from $12.07 to $16.71, with a likely average price of $14.89. Investors could expect a potential return of +121.41%.

September 2026

Our predictive algorithms indicate BioCryst Pharmaceuticals, Inc. stock may see a shift in September 2026. The expected range spans $9.46–$15.63, with an average target of $12.99. This represents a positive outlook and a possible gain of +93.16%.

October 2026

Analyzing established trends, BioCryst Pharmaceuticals, Inc. looks set to move in October 2026. Projections place the stock between $8.64 and $13.54, averaging around $11.59. This suggests a +72.34% gain from current levels.

November 2026

Market indicators suggest BioCryst Pharmaceuticals, Inc. could experience notable changes during November 2026. Prices could fluctuate within $7.59 to $14.69, with a midpoint forecast of $11.79. The stock might deliver a +75.32% gain.

December 2026

Forecasting for December 2026, models estimate that BioCryst Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.55 and $15.68, averaging $12.10. This signals a positive trajectory with potential returns around +79.93%.

January 2027

According to our latest forecast models, BioCryst Pharmaceuticals, Inc. (BCRX) is positioned to show a strong performance in January 2027. The price is predicted to move between $7.03 and $15.99, settling at an average of $12.97. This could translate to a +92.86% gain.

BCRX's history of dividends and stock splits also plays a role in long-term investor confidence.